查詢結果分析
來源資料
相關文獻
- Tuberculous Pleurisy with Effusion
- 蛋白質體學在結核性肋膜積液的研究
- Comparison of Tuberculous Empyema and Tuberculous Pleurisy in Terms of Risk Factors, Radiographic Findings and Biochemical Characteristics
- Thoracoamniotic Shunting for Treatment of Fetal Bilateral Hydrothorax with Hydrops
- Amoxicillin治療急性中耳炎之效果
- 急性中耳炎與慢性中耳積液--過敏科醫師的觀點
- Multiple Myeloma Presenting with a Paraspinal Tumor and Malignant Effusion: Case Report
- Comparison between Subxiphoid Approach and Left Thoracotomy in Surgical Treatment of Malignant Pericardial Effusion--The Experience of Taipei Veterans General Hospital
- 特發性鼓室出血與積液性中耳炎--病例報告
- 兒童中耳疾病對變頻耳聲傳射之影響
頁籤選單縮合
題 名 | Tuberculous Pleurisy with Effusion=伴有積液之結核性肋膜炎 |
---|---|
作 者 | 許至仁; 白冠壬; 姜義新; 吳銘斌; 林道平; 郭壽雄; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 98:10 1999.10[民88.10] |
頁 次 | 頁678-682 |
分類號 | 415.43 |
關鍵詞 | 積液; 結核性肋膜炎; Tuberculous pleurisy; Parenchymal involvement; Treatment outcome; |
語 文 | 英文(English) |
英文摘要 | To assess the clinical features of Taiwanese patients with tuberculous pleurisy and their response to treatment, we analyzed the records of patients treated for this condition from December 1990 through November 1995, at a regional 100-bed referral center for tuberculosis care. Diagnosis of tuberculous pleurisy was based on histologic evidence of caseating granulomatous inflammation in the pleural biopsy specimen, or evidence of mycobacteria in pleural fluid. Patients were also stratified on the basis of parenchymal involvement. Ninety-seven patients (79 men, 18 women) with a mean age of 47.5 (range 15-90) years were included in the analysis. The two major symptoms were cough (69%) and shortness of breath (57%). Chest roentgenographs showed that the pleural effusion was unilateral in 88(91%) patients, and small to moderate in amount in 74 (76%). Laboratory analysis of the pleural fluid showed moderate levels of glucose (4.6 mmol/L), with no significant difference between patients with and without parenchymal involvement. The levels of lactate dehydrogenase and triglycerides were significantly higher in patients with parenchymal involvement (172 vs 240.5 IU and 0.36 vs. 0.45 mmol/L, respectively). In 85 of 93 patients (91%) with available data, lymphocytes were predominant in the differential count. All patients had received shortcourse chemotherapy for at least 6 months. After excluding the defaulters and patients receiving subsequent management in other hospitals, the overall rate of successful treatment was 97% (72/74). There was no significant difference in the treatment outcome between patients with parenchymal involvement and those without. None of the successfully treated patients had a relapse within a mean follow-up period of 31.7 ± 18.4 months. We conclude that current patients with tuberculous pleurisy in Taiwan are not young, and short-course chemotherapy with isoniazid, ethambutol, rifampicin, and pyrazinamide is an effective treatment. The presence of parenchymal tuberculous lesions does not apper to influence the treatment outcome. |
本系統中英文摘要資訊取自各篇刊載內容。